SCHEDULE FILED TO REPORT ACQUISTION OF BENEFICAL OWNERSHIP

Company

Sunshine Biopharma Inc.

Filed

February 21, 2024

Accession Number

0001999371-24-002586

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →